Study on Cancer Profiling Market to 2022 - Dominated by NGS, Mass Spectrometry DNA and Microarray Applications

Cancer profiling market driven by cancer type, application, technology, and region. On basis of cancer type, cancer type market is categorized into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, & cancer types. In 2019, breast cancer segment is expected to account for largest share of global cancer/tumor profiling market.

Access Free Sample Copy of Cancer Profiling Market spread across 155 Pages, Profiling 11 Companies and Supported with 67 Tables and 32 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=268825 .

North America is expected to account for the largest share of the cancer/tumor profiling market in 2017, followed by Europe, APAC, and the RoW. The large share of the North American market is mainly attributed to the increasing government support for discovery and development of biomarkers, increasing demand for personalized medicine, adoption of advanced omics technologies for biomarker discovery, and rising use of biomarkers in drug discovery and development by pharmaceutical companies in that region.

Global cancer/tumor profiling market is projected to reach USD 8.74 billion in 2022 from USD 5.26 billion in 2017 at CAGR of 10.7%. Growth in cancer profiling market is driven by increasing number of cancer cases, growing utility of biomarker in tumor profiling, and availability of funding for cancer research.

Cancer profiling market dominated by established players Illumina (US), QIAGEN (Netherlands), Neo Genomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). Cancer profiling market in this report is segmented by cancer type, application, technology, and region.

Click Now for Discount on Cancer Profiling Market with Top Trends, Forecast, Analysis and Overview at https://www.prnewswire.com/in/news-releases/cancertumor-profiling-market-to-grow-at-107-cagr-to-2022–reportsnreports-668011633.html .

In cancer profiling market research addition, introduction and adoption of point-of-care diagnostic tests and development of personalized medicine are expected to offer growth opportunities for manufacturers of cancer/tumor profiling solutions.

Premium Insights

1 Cancer Profiling Market: Overview

2 Geographic Analysis: Cancer Profiling Market, By Technology (2017)

3 Cancer Profiling Market, By Application

4 Cancer Profiling Market, By Hybridization Technology

5 Geographical Snapshot of the Cancer Profiling Market

The cancer/tumor profiling market is categorized into clinical application, and research application. In 2017, the clinical application segment is expected to account for the largest share of the cancer/tumor profiling market. Technological advancements and the need for early diagnosis are further aiding market growth in this segment.